Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting innovative healthcare solutions, today announced that Frank D.

Laughing Water Capital, an investment management company, released its fourth-quarter 2024 investor letter. A copy of the ...

Lifecore’s board of directors has approved that holders of record of Lifecore’s Common Stock and Convertible Preferred Stock as of the close of business on February 18, 2025 (the “Record Date”), will ...

CHASKA, Minn., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing ...

Lifecore Biomedical, Inc. announced plans to hold a special stockholders meeting on April 10, 2025, to seek approval for a proposal related to its Series A Convertible Preferred Stock. The ...

Investorideas.com ( ), a go-to platform for big investing ideas for stock traders, including biotech and medical stocks ...

In a challenging turn of events for Ocean Biomedical, the company's stock has tumbled to a 52-week low, reaching a price ...

First Ascent Biomedical Secures $6 Million Investment from Vidal Duart Enterprises, Inc. to Revolutionize Cancer Treatment ...

A Providence law firm wants to cut ties with Ocean Biomedical, the once-celebrated Brown University startup that now faces a web of legal and financial troubles.

On January 16, 2025, Neuraly Inc. (Neuraly), a wholly owned subsidiary of D&D Pharmatech Inc., and Enigma Biomedical USA, Inc. (Enigma) announced the signing of a research license and ...